Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-127552
Filing Date
2012-03-22
Accepted
2012-03-22 16:48:34
Documents
25
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d262321d10k.htm 10-K 1254696
2 SYNAGEVA BIOPHARMA CORP. 2005 STOCK PLAN-FORM OF OPTION AGREEMENT d262321dex1012.htm EX-10.12 27138
3 FIRST AMENDMENT TO LEASE AGREEMENT DATED NOVEMBER 29, 2011 d262321dex1019.htm EX-10.19 40757
4 LEASE AGREEMENT, SYNAGEVA BIOPHARMA CORP. AND BARRETT INVESTMENT PROPERTIES, LLC d262321dex1020.htm EX-10.20 64982
5 SUBSIDIARIES OF THE REGISTRANT d262321dex211.htm EX-21.1 1625
6 CONSENT OF PRICEWATERHOUSECOOPERS LLP d262321dex231.htm EX-23.1 1604
7 RULE 13A-14(A) CERTIFICATION BY SANJ K. PATEL AS CHIEF EXECUTIVE OFFICER d262321dex311.htm EX-31.1 9296
8 RULE 13A-14(A) CERTIFICATION BY CARSTEN BOESS AS CHIEF FINANCIAL OFFICER d262321dex312.htm EX-31.2 9338
9 SECTION 1350 CERTIFICATION OF CEO AND CFO d262321dex321.htm EX-32.1 4765
16 GRAPHIC g262321ex10_19pg006a.jpg GRAPHIC 3429
17 GRAPHIC g262321ex10_19pg006b.jpg GRAPHIC 6277
18 GRAPHIC g262321ex10_19pg008.jpg GRAPHIC 115203
19 GRAPHIC g262321g02g23.jpg GRAPHIC 55955
20 GRAPHIC g262321g16p96.jpg GRAPHIC 29626
21 GRAPHIC g262321g18m36.jpg GRAPHIC 25344
22 GRAPHIC g262321g24t27.jpg GRAPHIC 34886
23 GRAPHIC g262321g71e38.jpg GRAPHIC 48095
24 GRAPHIC g262321g79y59.jpg GRAPHIC 53245
25 GRAPHIC g262321g84m52.jpg GRAPHIC 189277
  Complete submission text file 0001193125-12-127552.txt   5364185

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT geva-20111231.xml EX-101.INS 719153
11 XBRL TAXONOMY EXTENSION SCHEMA geva-20111231.xsd EX-101.SCH 18998
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE geva-20111231_cal.xml EX-101.CAL 29645
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE geva-20111231_def.xml EX-101.DEF 44583
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE geva-20111231_lab.xml EX-101.LAB 166217
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE geva-20111231_pre.xml EX-101.PRE 105971
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Filer) CIK: 0000911326 (see all company filings)

EIN.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23155 | Film No.: 12709681
SIC: 2836 Biological Products, (No Diagnostic Substances)